Title

Bcl10蛋白質在細胞核質位移之研究

Translated Titles

Investigation on the Mechanism(s) Mediating Bcl10 Protein Translocation Between Nucleus and Cytoplasm

DOI

10.6342/NTU.2004.00834

Authors

陳雯華

Key Words

胃相關黏膜組織淋巴瘤 ; Bcl10蛋白質 ; 胃幽門螺旋桿菌 ; MALT lymphoma ; MALT1 ; Bcl10 ; API2

PublicationName

臺灣大學微生物學研究所學位論文

Volume or Term/Year and Month of Publication

2004年

Academic Degree Category

碩士

Advisor

董馨蓮

Content Language

繁體中文

Chinese Abstract

胃相關黏膜組織淋巴瘤的發生與Helicobacter pylori的感染相當有關,所以在抗生素的治療下約有50%至70%的病患會痊癒;但仍有相當比例的病患無法以抗生素治療來治癒。而Bcl10蛋白質在核內的不正常表現被認為是這些無法以抗生素治療的病患相當重要的指標之一。以免疫組織染色觀察Bcl10蛋白質主要表現在正常B細胞的細胞質中,而其弁鄍D要是參與T細胞與B細胞受體調控NF-kB活化的路徑。所以在這篇論文裡我們所想要探討的問題是Bcl10是藉由何種機制的調控而進入細胞核。 第一部分,我們分析了包括T細胞淋巴瘤、Burkitt’s淋巴瘤、肝癌、鼻咽癌、子宮頸癌上皮、肺癌、以及乳癌等細胞株內Bcl10的表現及分佈。以北方及西方墨點分析皆發現在這些細胞株內的確有Bcl10蛋白質的表現。在這些細胞株內,Bcl10蛋白質分佈在細胞核與細胞質內,且這樣的細胞內分佈似乎與NF-kB活性的高低無關。 接下來,我們在Bcl10基因後面接上綠螢光蛋白基因(GFP)以便直接在顯微鏡下觀察Bcl10在細胞內的分佈;同時我們也製備Bcl10L41R來研究CARD domain對於調控Bcl10蛋白質在細胞內分佈的影響。Bcl10蛋白質和Bcl10GFP融合蛋白質在細胞內可以活化NF-kB,而Bcl10L41R蛋白質則失去活化NF-kB的能力,這樣的結果與其他的研究報告相符。大量表現Bcl10蛋白質和Bcl10GFP融合蛋白質,會在細胞質內形成絲狀構造;但CARD domain突變的Bcl10L41R和Bcl10L41RGFP融合蛋白質則均勻分佈在細胞核、質內。所以CARD domain對Bcl10活化NF-kB和形成絲狀構造相當重要。另外一方面,我們也在SDS-PAGE的實驗中發現Bcl10蛋白質的位置較Bcl10L41R蛋白質高;而以鹼性去磷酸酵素處理後Bcl10位置高於Bcl10L41R的這種現象就消失,因此Bcl10蛋白質在細胞內會被磷酸化。除此之外,我們也利用放射性磷酸鹽標定實驗證實Bcl10蛋白質的確會在細胞內會被磷酸化,而且CARD domain在Bcl10蛋白質的磷酸化過程中也扮演了相當重要的角色。 Bcl10GFP融合蛋白質在細胞內形成的絲狀構造並不會受到外界的刺激(如TPA、Sodium butyrate、UV、ionizing irradiation、TNF-ㄐ^而改變;但是HBx蛋白質卻可以藉由降低Bcl10GFP融合蛋白質的表現,使Bcl10GFP融合蛋白質在細胞內呈現均勻的分佈。但HBx蛋白質降低Bcl10GFP融合蛋白質表現的機制需進一步的研究探討。此外,我們也成左瑪鼢犍X可誘導穩定表現Bcl10GFP融合蛋白質的Hep G2細胞株。與之前在短暫細胞轉染的實驗中不同,Bcl10GFP融合蛋白質在細胞內並不會形成絲狀構造,而是呈現均勻的細胞內分佈。Bcl10GFP融合蛋白質在誘導細胞株與短暫細胞轉染間顯著不同的表現,我們將會在內文進行探討。

English Abstract

Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is highly associated with the infection of Helicobacter pylori. Approximately 50 to 70 % of patients with MALT lymphoma can be cured with anti-H. pylori antibiotic treatment. Aberrant nuclear expression of Bcl10 protein in MALT lymphoma cells was demonstrated to be one of the markers in patients showing no response to the antibiotic therapy. Bcl10 protein was shown to be an essential signaling molecule in TCR- (T cell receptor) or BCR- (B cell receptor) mediated NF-kB activation. Immunohistochemical analysis revealed that Bcl10 protein was mainly distributed in the cytoplasm of normal B cells. We would like to elucidate the molecular mechanism(s) mediating the aberrant nuclear translocation of Bcl10 protein in this study. Firstly, expression level and pattern of distribution of Bcl10 protein were examined in several mammalian cell lines, including T cell lymphoma, Burkitt’s lymphoma, hepatoma, nasopharyngeal carcinoma, cervical carcinoma, lung carcinoma and breast carcinoma. Northern blot and western blot analysis indicated that Bcl10 protein was ubiquitously expressed in all cell lines tested. Bcl10 protein was found to be distributed in both cytoplasm and nucleus irrespective of the NF-kB activity in these cell lines. Secondly, for direct visualization of Bcl10 protein under fluorescence microscope, expression vector with Bcl10 gene fused with green fluorescence protein (GFP) gene was generated. Meanwhile, mutant Bcl10L41R was generated to examine the role of CARD (caspase recruitment domain) domain in Bcl10-mediated effects. Bcl10 as well as Bcl10GFP fusion protein were shown to activate NF-kB activity in a reporter assay. Bcl10L41R mutant failed to activate NF-kB as reported by others. Overexpression of Bcl10 and Bcl10GFP fusion protein resulted in the formation of filamentous structure in the cytoplasm. Bcl10 mutants, Bcl10L41R and Bcl10L41RGFP, showed homogenous distribution in the cytoplasm and nucleus. These results indicated that intact CARD domain was essential for cytoplasmic filaments formation and NF-kB activation. Interestingly, in SDS polyacrylamide gel, wild type Bcl10 protein acted as a slower-migrating molecule as compared to mutant Bcl10L41R. Alkaline phosphatase treatment of wild type Bcl10 protein abrogated the slower-migrating phenomenon, implying that Bcl10 might be a phosphorylated protein. In-vivo phosphate labeling experiment confirmed that Bcl10 was modified by phosphorylation intracellularly and CARD domain was essential in the process. While a lot of stress-inducing agents (such as TPA, sodium butyrate, UV, ionizing irradiation. TNF-a) failed to affect the cytoplasmic filamentous structure of ectopically-expressed Bcl10GFP protein, hepatitis B virus X protein (HBx) reduced the expression level of Bcl10GFP, resulting in a homogenous distribution of Bcl10GFP protein inside the cells. The molecular mechanism by which HBx reduced the expression level of Bcl10GFP awaits further investigation. Also, we have successfully cloned a Hep G2 cell line with inducible expression of Bcl10GFP fusion protein. Different from the cytoplasmic filamentous structure as seen in the transient transfection experiment, Bcl10GFP showed homogenous distribution in the nucleus and cytoplasm in this selected clone. The significance of these findings will be discussed in the text.

Topic Category 醫藥衛生 > 基礎醫學
醫學院 > 微生物學研究所
Reference
  1. Bertin, J., Guo, Y., Wang, L., Srinivasula, S. M., Jacobson, M. D., Poyet, J. L., Merriam, S., Du, M. Q., Dyer, M. J., Robison, K. E., et al. (2000) CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B. J. Biol. Chem. 275, 41082-41086.
    連結:
  2. Bodero, A. J., Ye, R., and Lees-Miller, S. P. (2003) UV-light induces p38 MAPK-dependent phosphorylation of Bcl10. Biochem. Biophys. Res. Commun. 301, 923-926.
    連結:
  3. Che, T., You, Y., Wang, D., Tanner, M. J., Dixit, V. M., and Lin, X. (2004) MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation. J. Biol. Chem. 279, 15870-15876.
    連結:
  4. Chen, M., Li, L. Y., and Qi, Y. P. (2003) Bcl10 protein can act as a transcription activator in yeast. Mol. Cell. Biochem. 246, 97-103.
    連結:
  5. Costanzo, A., Guiet, C., and Vito, P. (1999). c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaB. J. Biol. Chem. 274, 20127-20132.
    連結:
  6. Du, M. Q., and Isaccson, P. G. (2002) Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol. 3, 97-104.
    連結:
  7. Guiet, C., and Vito, P. (2000) Caspase recruitment domain (CARD)-dependent cytoplasmic filaments mediate bcl10-induced NF-kappaB activation. J. Cell. Biol. 148, 1131-1140.
    連結:
  8. Gaide, O., Favier, B., Legler, D. F., Bonnet, D., Brissoni, B., Valitutti, S., Bron, C., Tschopp, J., and Thome, M. (2002) CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation. Nat. Immunol. 3, 836-843.
    連結:
  9. Gaide, O., Martinon, F., Micheau, O., Bonnet, D., Thome, M., and Tschopp, J. (2001) Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation. FEBS Lett. 496, 121-127.
    連結:
  10. Hofmann, K. (1999) The modular nature of apoptotic signaling proteins. Cell. Mol. Life Sci. 55, 1113-1128.
    連結:
  11. Hosokawa, Y., Suzuki, H., Suzuki, Y., Takahashi, R., and Seto, M. (2004) Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t (11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma. Cancer Res. 64, 3452-3457.
    連結:
  12. Isaacson, P., and Wright, D. H. (1983) Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 52, 1410-1416.
    連結:
  13. Liu, H., Ye, H., Dogan, A., Ranaldi, R., Hamoudi, R. A., Bearzi, I., Isaacson, P. G., and Du, M. Q. (2001) T (11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 98, 1182-1187.
    連結:
  14. Liu, Y., Dong, W., Chen, L., Zhang, P., and Qi, Y. (2004) Characterization of Bcl10 as a potential transcriptional activator that interacts with general transcription factor TFIIB. Biochem. Biophys. Res. Commun. 320, 1-6.
    連結:
  15. Lucas, P. C., Yonezumi, M., Inohara, N., McAllister-Lucas, L. M., Abazeed, M. E., Chen, F. F., Yamaoka, S., Seto, M., and Nunez, G. (2001) Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J. Biol. Chem. 276, 19012-19019.
    連結:
  16. Lucas, P. C., McAllister-Lucas, L. M., and Nunez, G. (2004) NF-kappaB signaling in lymphocytes: a new cast of characters. J. Cell Sci. 117, 31-39.
    連結:
  17. Koseki, T., Inohara, N., Chen, S., Carrio, R., Merino, J., Hottiger, M. O., Nabel, G. J., and Nunez, G. (1999) CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10. J. Biol. Chem. 274, 9955-9961.
    連結:
  18. McAllister-Lucas, L. M., Inohara, N., Lucas, P. C., Ruland, J., Benito, A., Li, Q., Chen, S., Chen, F. F., Yamaoka, S., Verma, I. M., et al. (2001) Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction. J. Biol. Chem. 276, 30589-30597.
    連結:
  19. Maes, B., Demunter, A., Peeters, B., and De Wolf-Peeters, C. (2002) BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression. Blood 99, 1398-1404.
    連結:
  20. Mullauer, L., Gruber, P., Sebinger, D., Buch, J., Wohlfart, S., and Chott, A. (2001) Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat. Res. 488, 211-231.
    連結:
  21. Pomerantz, J. L., Denny, E. M., and Baltimore, D. (2002) CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex. EMBO. J. 21, 5184-5194.
    連結:
  22. Shen, L., Liang, A. C., Lu, L., Au, W. Y., Wong, K. Y., Tin, P. C., Chan, K. W., Ko, K. H., Chen, Y. W., Beh, S. L., et al. (2003) Aberrant BCL10 nuclear expression in nasal NK/T-cell lymphoma. Blood 102, 1553-1554.
    連結:
  23. Srinivasula, S. M., Ahmad, M., Lin, J. H., Poyet, J. L., Fernandes-Alnemri, T., Tsichlis, P. N., and Alnemri, E. S. (1999) CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis. J. Biol. Chem. 274, 17946-17954.
    連結:
  24. Ruefli-Brasse, A. A., Lee, W. P., Hurst, S., and Dixit, V. M. (2004) Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation. J. Biol. Chem. 279, 1570-1574.
    連結:
  25. Sanchez-Beato, M., Sanchez-Aguilera, A., and Piris, M. A. (2003) Cell cycle deregulation in B-cell lymphomas. Blood 101, 1220-1235.
    連結:
  26. Schaefer, B. C., Kappler, J. W., Kupfer, A., and Marrack, P. (2004) Complex and dynamic redistribution of NF-kappaB signaling intermediates in response to T cell receptor stimulation. Proc. Natl. Acad. Sci. U S A 101, 1004-1009.
    連結:
  27. Scharschmidt, E., Wegener, E., Heissmeyer, V., Rao, A., and Krappmann, D. (2004) Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling. Mol. Cell. Biol. 24, 3860-3873.
    連結:
  28. Sun, L., Deng, L., Ea, C. K., Xia, Z. P., and Chen, Z. J. (2004) The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14, 289-301.
    連結:
  29. Thome, M., and Tschopp, J. (2003) TCR-induced NF-kappaB activation: a crucial role for Carma1, Bcl10 and MALT1. Trends Immunol. 24, 419-424.
    連結:
  30. Thome, M. (2004) CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat. Rev. Immunol. 4, 348-359.
    連結:
  31. Uren, A. G., O'Rourke, K., Aravind, L. A., Pisabarro, M. T., Seshagiri, S., Koonin, E. V., and Dixit, V. M. (2000) Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell 6, 961-967.
    連結:
  32. Wang, L., Guo, Y., Huang, W. J., Ke, X., Poyet, J. L., Manji, G. A., Merriam, S., Glucksmann, M. A., DiStefano, P. S., Alnemri, E. S., and Bertin, J. (2001) Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B. J. Biol. Chem. 276, 21405-21409.
    連結:
  33. Willis, T. G., Jadayel, D. M., Du, M. Q., Peng, H., Perry, A. R., Abdul-Rauf, M., Price, H., Karran, L., Majekodunmi, O., Wlodarska, I., et al. (1999) Bcl10 is involved in t (1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96, 35-45.
    連結:
  34. Xue, L., Morris, S. W., Orihuela, C., Tuomanen, E., Cui, X., Wen, R., and Wang, D. (2003) Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells. Na.t Immunol. 4, 857-865.
    連結:
  35. Yan, M., Lee, J., Schilbach, S., Goddard, A., and Dixit, V. (1999) mE10, a novel caspase recruitment domain-containing proapoptotic molecule. J. Biol. Chem. 274, 10287-10292.
    連結:
  36. Yoneda, T., Imaizumi, K., Maeda, M., Yui, D., Manabe, T., Katayama, T., Sato, N., Gomi, F., Morihara, T., Mori, Y., et al. (2000) Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated protein. J. Biol. Chem. 275, 11114-11120.
    連結:
  37. Yui, D., Yoneda, T., Oono, K., Katayama, T., Imaizumi, K., and Tohyama, M. (2001) Interchangeable binding of Bcl10 to TRAF2 and cIAPs regulates apoptosis signaling. Oncogene 20, 4317-4323.
    連結:
  38. Zhang, Q., Siebert, R., Yan, M., Hinzmann, B., Cui, X., Xue, L., Rakestraw, K. M., Naeve, C. W., Beckmann, G., Weisenburger, D. D., et al. (1999) Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t (1;14)(p22;q32). Nat. Genet. 22, 63-68.
    連結:
  39. Ye, H., Dogan, A., Karran, L., Willis, T. G., Chen, L., Wlodarska, I., Dyer, M. J., Isaacson, P. G., and Du, M. Q. (2000) BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. Am. J. Pathol. 157, 1147-1154.